Donald Trump

Five things for pharma marketers to know: Thursday, February 8, 2018

Five things for pharma marketers to know: Thursday, February 8, 2018

By

FDA approval of Gilead HIV drug prompts ViiV patent suit; Poll shows split in voter reaction to Trump opioid plan; Outcome Health partners with CDC.

Five things for pharma marketers to know: Wednesday, January 31, 2018

Five things for pharma marketers to know: Wednesday, January 31, 2018

By

CDC chief resigns; Amazon healthcare entry raises data concerns; Trump promises to make lower drug prices 'a priority'

Trump administration raises questions for rare-disease drugmakers

Trump administration raises questions for rare-disease drugmakers

By

Nobody knows what the future holds for the Affordable Care Act under the Trump administration and an emboldened Republican Congress.